FORT LAUDERDALE, FL -- (Marketwire) -- 09/02/09 -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI)subsidiary Star brite Distributing, Inc. obtained an injunction in USFederal Court against ValvTect for false and deceptive advertising in theirads comparing ValvTect Ethanol Gas Treatment to Star brite's Star TronEnzyme Fuel Treatment.The U.S. District Court ordered a preliminary injunction against ValvTectfrom further running false and misleading comparison advertising ofValvTect Ethanol Gasoline Treatment. Furthermore, the Court stated thatgranting a "preliminary injunction is an extraordinary and drastic remedy."
The Court ruled all four points of ValvTect's comparison ads are falseand/or misleading and deceived the public. ValvTect claimed test resultsproved their product performed better, yet the Court found they failed torun their tests using E10 (Ethanol fuel), even though the ads and productsare about E10 (Ethanol fuel). ValvTect claimed independent testing, yet theCourt found one of the tests was run by a ValvTect supplier and was notindependent. ValvTect inferred approvals from major OEMs including BMW,Ford and Chrysler, yet the Court found there were no such approvals. Everysingle point of the ValvTect ads has been found to be false or misleadingby the Court.
Star brite CEO Peter Dornau says, "It is clear to me that the Courtrealized the ValvTect ads were blatantly false and deceptive to theboat-owning public."
Dornau says, "The court also pointed out that ValvTect incorrectly usedASTM and NACE tests which do not allow for the testing of E10 fuel and haveno relevance to the marine industry. We appreciate the strength and clarityof the Court's findings against the false and misleading advertising byValvTect. This type of false advertising not only hurts Star brite but theentire marine industry by confusing customers about the truth and fictionof Ethanol fuel additives."
About Ocean Bio-Chem
Ocean Bio-Chem, Inc. manufactures and markets a full line of maintenanceand care products for boats, recreational vehicles, automobiles,motorcycles and aircraft. Products are sold under the Star brite® name.The Company trades publicly under NASDAQ SmallCap Symbol: OBCI. Websites:www.starbrite.com, www.startron.com, www.oceanbiochem.com
NOTE: The foregoing is news relating to Ocean Bio-Chem, Inc. (OBCI or "theCompany") and contains forward-looking statements, which are made pursuantto the safe harbor provisions of the Private Securities Litigation ReformAct of 1995. The forward-looking statements involve risks anduncertainties that could cause actual results to differ materially from theforward-looking statements. When used in this report, the words"anticipate," "believe," "estimate," "expect" and similar expressions asthey relate to the Company or its management, including without limitationthe Company's other subsidiaries, are intended to identify suchforward-looking statements. The Company's actual results, performance orachievements could differ materially from the results expressed in, orimplied by these forward-looking statements. For more detailed informationthe reader is referred to the Company's 10-K and other documents filed withthe United States Securities and Exchange Commission. This does notconstitute an offer to buy or sell securities by the Company or itssubsidiaries and is meant purely for informational purposes.
For additional information contact:
Peter Dornau
President and CEO
Ocean Bio-Chem, Inc.
peter@starbrite.com
(954) 587-6280
Jeff Barocas
Chief Financial Officer
Ocean Bio-Chem, Inc.
jbarocas@starbrite.com
(954) 587-6280
Ocean Bio-Chem, Inc.
4041 S. W. 47th Avenue
Fort Lauderdale, FL 33314
Nasdaq SmallCap Symbol: OBCI